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Pneumolysin, a major virulence factor of the human
pathogen Streptococcus pneumoniae, is a soluble protein
that disrupts cholesterol-containing membranes of cells
by forming ring-shaped oligomers. Magic angle spinning
and wideline static 31P NMR have been used in combi-
nation with freeze-fracture electron microscopy to in-
vestigate the effect of pneumolysin on fully hydrated
model membranes containing cholesterol and phos-
phatidylcholine and dicetyl phosphate (10:10:1 molar ra-
tio). NMR spectra show that the interaction of pneumo-
lysin with cholesterol-containing liposomes results in
the formation of a nonbilayer phospholipid phase and
vesicle aggregation. The amount of the nonbilayer phase
increases with increasing protein concentration.
Freeze-fracture electron microscopy indicates the coex-
istence of aggregated vesicles and free ring-shaped
structures in the presence of pneumolysin. On the basis
of their size and analysis of the NMR spectra it is con-
cluded that the rings are pneumolysin oligomers (con-
taining 30–50 monomers) complexed with lipid (each
with 840–1400 lipids). The lifetime of the phospholipid
in either bilayer-associated complexes or free pneumo-
lysin-lipid complexes is > 15 ms. It is further concluded
that the effect of pneumolysin on lipid membranes is a
complex combination of pore formation within the bi-
layer, extraction of lipid into free oligomeric complexes,
aggregation and fusion of liposomes, and the destabili-
zation of membranes leading to formation of small
vesicles.
Pneumolysin is a major virulence factor from the human
pathogen Steptococcus pneumoniae and is a member of a family
of cholesterol-binding toxins (CBTs),1 which also includes per-
fringolysin from Clostridium perfringens, listeriolysin from
Listeria monocytogenes, and streptolysin from Streptococcus
pyogenes. Streptolysin is well known for its use in cell biology
for the permeabilization of cells. As well as pore formation
leading to the breakdown of membrane barriers into cells and
between tissues, these toxins act in a complex manner involv-
ing the activation of intracellular signaling pathways and the
induction of inflammation, among other responses (see Morgan
et al. (1) for review). Understanding the mechanisms by which
CBTs act has been greatly assisted by the determination of a
crystal structure for soluble, monomeric perfringolysin (2) and
the use of electron cryo-microscopy (cryo-EM) to obtain three-
dimensional reconstructions of the oligomeric and pore-forming
states of CBTs using pneumolysin (3). These direct structural
insights have been augmented by results obtained by Tweten
and co-workers (4) using fluorescence spectroscopy (5), which
demonstrate that a pendant domain of the CBTs interacts with
phospholipid molecules during pore formation via two a-helix
bundles refolded into two b-hairpins. A second terminal do-
main is known to be involved in membrane binding via choles-
terol. Thus, it seems that the CBT mechanism involves two
domains interacting with the membrane (6, 3).
Two mechanisms for pneumolysin action in disease are well
defined (7). First, pneumolysin is well known as a pore-forming
toxin that binds to cholesterol in membranes, oligomerizes into
ring-shaped assemblies, and undergoes conformational
changes causing it to penetrate and form a pore within the
bilayer (3). Secondly, pneumolysin activates the complement
system in a nonimmunospecific manner as a result of interac-
tion with IgG-Fc and complement proteins (8, 9).
Solid state NMR provides a direct and quantitative way for
investigating lipid-protein interactions in membranes (10–12).
Changes in protein-induced phospholipid phase behavior can
be observed through characteristic intensity distribution in the
chemical shift anisotropy (CSA)-dominated lineshapes of wide-
line 31P NMR spectra. Characteristic lineshapes have been
observed from phospholipid phases with different modes of
molecular motions (Fig. 1 and Refs. 13–15). Using 31P magic
angle spinning (MAS) NMR, the individual lipid components in
the bilayer can be resolved (11), and changes in their isotropic
chemical shift, CSA and full-width at half-height (FWHH) in
response to modulation of the phosphate motions in the pres-
ence of proteins determined (11, 12, 16).
Here results from solid-state NMR and electron microscopy
are presented that provide novel insights into the mechanism
of CBTs and complement data already acquired using other
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techniques. Suspensions of cholesterol-containing liposomes
are a model system that has already been used for analysis of
pore formation by pneumolysin using small-angle neutron scat-
tering (9) and cryo-EM (3).
MATERIALS AND METHODS
Sample Preparation—Large unilamellar vesicles (LUVs) of egg-yolk
phosphatidylcholine (PC), cholesterol, and dicetylphosphate (DCP) in a
10:10:1 molar ratio were prepared in 100 mM Tris buffer, pH 7.5, at 5
mM concentration as previously described (3). Multilamellar vesicles
(MLVs) used in a control experiment were prepared by five cycles of
rapid freezing of hydrated lipid mixtures followed by 15 min equilibra-
tion at 40 °C. Pneumolysin was expressed from recombinant Esche-
richia coli and purified as previously described (17). Pneumolysin was
mixed with liposomes at a variety of molar ratios to cholesterol and
incubated at 37 °C for 10 min prior to data acquisition.
NMR Spectroscopy—Phosphorus-31 wideline and MAS NMR meas-
urements were carried out on a CMX Infinity 500 spectrometer at a
proton frequency of 500 MHz. Typically 5 mmol of lipid dispersion were
used in a 4-mm rotor using an HX Apex probe. A single 90° pulse was
used for detection with broadband decoupling at the proton frequency
during acquisition. The 90° pulse length was 4 ms, and the strength of
the proton decoupling field was 20 kHz. The dwell time used was 40 ms,
and 2048 points were collected in each experiment. Between 300 and
3000 transients were averaged for each free induction decay (FID)
during MAS experiments and between 5000 and 10,000 during wideline
experiments with a 5-s delay (exceeding 5T1) between acquisitions in all
cases. The sample rotation speed was maintained at 12 kHz during
acquisition of the MAS spectra, and the temperature was set to 30 °C
for all experiments.
High speed MAS lineshape analysis was performed by fitting simu-
lated Lorentzian lines to the experimental spectra using Spinsight
(Chemagnetics, Fort Collins, CO) and Felix (MSI, Cambridge). The
intensity of the individual lines was estimated from the integral of the
simulated spectra. All 31P chemical shifts are measured relative to 0
ppm for 10% v/v phosphoric acid. All spectra were obtained with 50 Hz
linebroadening for the wideline spectra and 10 Hz for the MAS spectra.
Electron Microscopy—Samples of LUV suspensions from NMR ex-
periments were prepared for freeze-fracture by equilibration at room
temperature, followed by a rapid immersion into liquid butane at its
solidification point (18). Fracture of the immobilized frozen droplets
was performed at 2100 °C, followed by platinum shadowing at 45° with
respect to the fractured surface and a normal deposition of a uniform
carbon film in a Balzers freeze-etching apparatus. Residual sample was
removed from the carbon-platinum replicas by cyclic exposure to potas-
sium hypochlorate and methanol. The carbon-platinum replicas were
transferred onto copper electron microscope grids. A Phillips CM120
transmission electron microscope was used for grid visualization at
100-kV accelerating voltage and 45,000 3 magnification.
RESULTS
Lipid Dynamics and Phase Behavior-Phosphorus-31 Wide-
line NMR—Wideline 31P NMR was used to monitor changes in
the phospholipid phase behavior induced by the addition of
pneumolysin. LUVs of egg yolk PC, cholesterol, and DCP (mo-
lar ratio 10:10:1) were incubated with pneumolysin at 30 °C.
Spectra from the lipid vesicles alone (see Fig. 2a) and in the
presence of pneumolysin at different concentrations are shown
(Fig. 2, b–d). The 31P NMR spectrum from lipid suspension
prior to addition of pneumolysin (Fig. 2a) consists of a single
narrow line. The collapse of the phosphorus CSA is because of
fast rotation of relatively small (,100 nm in diameter) unila-
mellar vesicles (19). The correlation times (tR) for tumbling of
such vesicles are on the order of 1024–1025 s, which exceeds the
inverse width of the average 31P CSA (;40–50 ppm, ;6 kHz)
for lipid phosphates in extended bilayers.
Fig. 2b shows the spectrum from the phospholipid dispersion
after addition of pneumolysin at 0.5 mol % with respect to
cholesterol. The spectrum is characteristic of a 31P CSA-domi-
nated spherically averaged (powder) pattern (20) from phos-
pholipid bilayers in extended structures of average size greatly
exceeding 100 nm. The most likely cause of this change in
apparent liposome size when compared with protein-free lipo-
somes (Fig. 2a) is vesicle aggregation induced by the interac-
tion of toxin with the membranes. The motional properties of
these complexes indicate that the average size of the lipid
aggregates exceeds 1 mm because their reorientation rate
FIG. 1. Simulated characteristic lineshapes from spherically
symmetric lipid distribution (bilayer phase, a) and cylindrically
symmetric lipid distribution (HII phase, b) with the same effec-
tive CSA. Lineshapes were simulated using Maple 6 (University of
Waterloo, Canada).
FIG. 2. Wideline 31P NMR spectra from egg PC/cholesterol/
DCP LUV dispersions in a molar ratio of 10:10:1 (a) and after
addition of 0.5 mol % (b), 1.25 mol % (c), and 1.5 mol % (d)
pneumolysin. A dotted and a dashed line are added to the spectrum in
b to identify the spectral contribution from the bilayer PC (below dotted
line), nonbilayer lipid (between dotted and dashed lines), and bilayer
DCP (above dashed line). See text for details.
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(tR
21) is much lower than 6 kHz (the effective CSA of lipid
phosphates). The spectrum of Fig. 2b reveals three overlapping
features, a powder pattern between ;27 and 214 ppm (below
dotted line), a second powder pattern with reduced effective
CSA from 5 to 22 ppm (above dashed line), and an inverted
powder-like distribution from 3 to about 28 ppm (Fig. 2, be-
tween dotted and dashed lines, see characteristic lineshapes).
The two powder patterns arise from a spherical distribution of
lipid molecules rapidly rotating about their long axes. The
downfield intense feature in the powder patterns corresponds
to molecules oriented at 90 degrees with respect to the external
magnetic field and the upfield distribution of intensity to mol-
ecules oriented along the field. The width of the broader powder
pattern (below dotted line) is characteristic of phosphatidylcho-
line aggregates undergoing slow reorientation and is likely to
result from liposomes aggregated in the presence of pneumoly-
sin. The narrow powder pattern (above dashed line) is gener-
ated by the phosphates of DCP in the same lipid bilayer. These
powder distributions can be observed as a result of the inter-
action between the vesicles in the presence of pneumolysin. The
relative intensity of the powder patterns with respect to each
other is independent of the amount of toxin added to the lipid
suspension (Fig. 2, b–d), which suggests that the PC/DCP ratio
in the bilayer remains constant. In a control experiment, an
MLV (large complexes with tR
21 .. effective CSA) suspension
produced a wideline 31P NMR spectrum (Fig. 3) consisting of
two powder patterns of comparable relative intensity and of
similar effective CSA to the powder patterns observed in the
presence of pneumolysin (Fig. 2).
The inverted powder-like feature of Fig. 2b is characterized
by a sharp upfield edge, arising from molecules oriented at 90
degrees with respect to the external field and a downfield
extended region from lipids oriented along the magnetic field.
Inverted powder-like patterns arise from nonbilayer lipid com-
plexes with cylindrical symmetry of motion like, for example,
the lipid tubular structures in inverted hexagonal (HII) phases
(14). The effective CSA, measured from these patterns (;11
ppm), is less than the expected half-spectral width from the
bilayer environment (;40 ppm) and exceeds the measured
effective CSA of the narrow powder pattern (associated with
the presence of DCP). This suggests that fast rotation of the
phospholipid aggregates in the axially symmetric environment
results in additional reduction in the effective CSA and ex-
cludes the possibility of formation of a cylindrically symmetric
lipid distribution from the lipid environment with small effec-
tive CSA by a simple reduction of spherical to cylindrical sym-
metry. In the latter case, the width of the axially symmetric
distribution would be derived as a half of the effective CSA in
the related spherical distribution (14, 15).
Further increase in the pneumolysin concentration results in
a relative increase in the intensity of the cylindrical lipid dis-
tribution and a decrease in the intensity of both powder pat-
terns (Fig. 2, c and d). This behavior shows that the cylindrical
lipid population arises from a pneumolysin-associated lipid
environment. The good spectral definition of the characteristic
edges of the lipid environments indicates well separated phases
with none or with very slow (tex
21 , 200 Hz), lipid exchange
between them. The 90° edges from the different lipid environ-
ments remain at the same chemical shift, which suggests that
the effective CSA and, therefore, the motional characteristics of
these environments are independent of pneumolysin
concentration.
Quantification of the Pneumolysin-Lipid Interaction by Phos-
phorus-31 MAS NMR—Phosphorus-31 MAS NMR is used here
as a high-resolution approach to membrane studies for quan-
titative characterization of the different phospholipid environ-
ments (11). High speed MAS 31P NMR spectra from different
lipid-pneumolysin mixtures are shown in Fig. 4. The lipid sus-
pension in the absence of toxin gives rise to a single resonance
at ;0 ppm. The observed unusual chemical shift of the reso-
nance line and the lack of resolution between PC and DCP are
most likely because of an interference of the vesicle tumbling
and lateral diffusion of the phospholipid molecules with the
proton-phosphorus decoupling and MAS. Such interaction may
result in inefficient proton decoupling and incomplete averag-
ing of the 31P CSA under MAS for 100 nm LUVs (see Ref. 21 for
discussion). In a control 31P MAS NMR experiment an MLV
suspension of the same composition produced a strong reso-
nance at approximately 21.0 ppm, attributed to the PC phos-
phate and a weak resonance at 0.1 ppm from DCP (spectrum
not shown).
All 31P MAS NMR spectra in the presence of pneumolysin
FIG. 3. Wideline 31P NMR spectrum from an egg PC/cholester-
ol/DCP MLV dispersion in a molar ratio of 10:10:1. The dotted lines
help distinguish the PC powder pattern (bottom) from the DCP powder
pattern (top).
FIG. 4. Phosphorus-31 MAS NMR spectra from egg PC/choles-
terol/DCP LUV dispersions in a molar ratio of 10:10:1 (a) and
after addition of 0.5 mol % (b), 1.25 mol % (c), and 1.5 mol % (d)
pneumolysin. See text for details.
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show two distinctive resonances, (Fig. 4, b–d), a downfield one
at approximately 21.0 ppm and an upfield resonance with
chemical shift dependent on the pneumolysin concentration
(Table I). The resonance at 21.0 ppm has the characteristic
chemical shift of phosphatidylcholine in a bilayer environment
(11) and consists of two overlapping resonances, one of FWHH
approximately equal to 1.61 ppm and another of 0.35 ppm
FWHH. The FWHH of the broader resonance increases at
higher pneumolysin concentration, whereas that of the nar-
rower resonance does not show a clear dependence on toxin
concentration. The broader resonance, therefore, probably
arises from pneumolysin-associated lipid within the lipid bi-
layer phase in the form of pores (see EM evidence below) or
between partially fused liposomes. A low intensity resonance at
0.1 ppm arises from DCP in the bilayer. The ratio between its
intensity and the intensity of the PC at 21.0 ppm resonance
does not depend on pneumolysin concentration.
The narrow upfield resonance (Fig. 4b) undergoes a pro-
nounced further upfield change in its isotropic chemical shift,
s, with increasing pneumolysin concentration (Table I). The
relative intensity of this resonance when compared with the
total intensity of the line at 21.0 ppm increases as the toxin
concentration is increased (Table I). The toxin concentration-
dependent increase in the intensity of this resonance parallels,
in a qualitative way, the increase in the intensity of the reverse
powder pattern, observed in the static spectra (Fig. 2, b–d).
Therefore, the upfield resonance most likely arises from lipid
associated with pneumolysin in the nonbilayer environment.
Morphology of the Lipid Phases by Freeze-Fracture EM—
Freeze-fracture electron microscopy was used to obtain infor-
mation about the lipid phase topology in the presence of pneu-
molysin. Fig. 5 shows transmission electron micrographs from
the lipid system in the presence of 1.25 mol % pneumolysin
with respect to cholesterol. The micrographs show aggregated
lipid vesicles, with the vesicles varying in size from one hun-
dred to a few hundred nanometers. Fractures across the vesi-
cles reveal single or only a few bilayers and thus the absence of
multibilayer structures. Nonaggregated vesicles are also seen
in coexistence with the vesicle aggregates. Multifaceted lipo-
some surfaces reveal close foam-like aggregation. The surfaces
of some liposomes show the presence of circular structures of
;25 nm internal diameter (Fig. 5a, arrow p). Previously ob-
served pneumolysin oligomers have a similar size to these
circular structures and represent, most likely, membrane-in-
corporated oligomeric toxin pores (3).
Free ring-shaped structures unassociated with liposomes are
also observed with an inside diameter of ;25 nm and an
outside diameter of about 50 nm (Fig. 5a, arrow r). These
appear to be the only axially symmetric structures in the sys-
tem and are the same size as the rings seen here on liposomes,
and previously on liposomes in solution (3). Fig. 5b (arrow)
shows a structure of the same size (;25-nm inner diameter) as
the rings of Fig. 5a, localized at the boundary between two
liposomes having a common wall. This suggests that pneumo-
lysin oligomers play a role in liposome aggregation and fusion.
A lipid environment resembling that in the proteolipid rings is
associated with the pneumolysin ring shown in Fig. 5b. This
suggests that vesicle aggregation may be related to the forma-
tion of nonbilayer proteolipid structures.
DISCUSSION
An important aspect of the effect of pneumolysin on mem-
branes is the destabilizing effect the protein has on the lipid
bilayers and the associated withdrawal of phospholipids into
nonbilayer structures. The wideline 31P NMR spectra (Fig. 2,
b–d) originate from a coexistence of phospholipids in structures
with a spherically averaged CSA corresponding to the CSA of
slowly tumbling MLV’s, together with a nonbilayer phase with
axially symmetric motion of the lipid structures. The changes
in intensity distribution from a powder, to a distribution with
the 90° edge located upfield with respect to the 0° extreme, are
indicative of the presence of an additional axis of phospholipid
molecular averaging, perpendicular to the main axis of lipid
rotation. This situation is observed, for example, in the pres-
ence of inverted hexagonal (HII) phases (15, 22). In addition to
the inversion of spectral intensity distribution, the overall
width of the CSA-dominated intensity distribution is expected
to decrease by a factor of 2 (see Fig. 1 and Refs. 13, 15). The
width of the spectrum from the pneumolysin-induced nonbi-
layer phase (;10 ppm) is reduced further to ;one-fourth of the
spectral width from the lipid powder distribution (;40 ppm).
This suggests the presence of fast axial rotation of the lipids in
these structures and that they are smaller than the average
diameter of a lipid aggregate in an HII phase. The increase in
the fraction of the nonbilayer phase with increasing toxin con-
centration strongly indicates that its formation is induced by
pneumolysin (Fig. 2, b–d).
The ring structures, shown in the micrographs in Fig. 5
possess all the characteristics necessary to give rise to the
inverted powder component in the static 31P NMR spectra of
Fig. 2, b–d. Their ring shape results in a preferred axis of
motional averaging and their relatively small size would facil-
itate fast axial rotation. The internal diameter of these struc-
tures corresponds to the size of pneumolysin rings observed by
negative staining EM and cryo-EM (3, 17). The most likely
explanation for the rings seen here by EM and detected by a
characteristic spectral distribution similar to that of a nonbi-
layer phase (Fig. 2) is an oligomeric pneumolysin ring with a
lipid annulus decorating the exterior of the oligomer (Fig. 6).
The interior of such structures could be filled with lipid or
empty, because both forms of oligomers have been observed by
cryo-EM (3).2 In either case the evolution of such structures
into free solution from liposomes, with which pneumolysin
interacts would result in the rapid destruction of the
membrane.
The relative intensity of the nonbilayer spectral feature in-
creases in comparison to the intensities of both the wide and
the narrow powder patterns. The concomitant increase in the
intensity of the upfield resonance in the 31P MAS NMR spectra
can be used as a measure of the relative amount of nonbilayer
phase (proteolipid rings). Thus the quantitation of spectral
intensity (Table I) reflects the fraction of the total lipid, segre-
gated into the rings and indicates that a large proportion of the
lipid is associated with free oligomers detached from the lipid
bilayer. In particular, the values presented in Table I show that
an increase in pneumolysin concentration with respect to cho-
2 R. J. C. Gilbert, J. L. Jimenez, S. Chen, and H. R. Saibil, unpub-
lished results.
TABLE I
Phosphorous-31 isotropic chemical shifts
Phosphorous-31 isotropic chemical shifts (sp, sf) from MAS NMR of
the non-bilayer and total bilayer lipid resonance and relative intensity
I as a fraction of the total spectral intensity determined from the
spectra in Fig. 2 for different concentrations of pneumolysin with re-
spect to cholesterol at 30 °C are shown.
Pneumolysin sp
a sf Ip If
mol % ppm ppm % %
0.00 0.00 0.00 0 100
0.50 0.65 21.04 32 68
1.25 1.01 21.05 40 60
1.50 1.12 21.05 60 40
a Bilayer lipid is in LUVs and not in the extended bilayers.
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lesterol from 0.5 to 1.5 mol % results in an increase of nonbi-
layer phase from 32 to 60% of the total phospholipid content.
Consequently, in the presence of ;1 mol % of pneumolysin, 28
phospholipid molecules are associated with each pneumolysin
monomer and the number of phospholipid molecules per oli-
gomer, consisting of 30 to 50 toxin molecules (3), can be esti-
mated to vary between 840 and 1400, respectively.
The insights gained here into the mechanism of CBTs are
fundamentally important because they suggest that toxin pores
do not remain associated with bilayer membranes or bilayer
fragments derived from cells, which have been lysed. On the
contrary, they become dispersed in complexes with phospholip-
ids and possibly also cholesterol. However, fluorescence studies
on the CBT perfringolysin have been interpreted on the pre-
mise that the lipids with which the toxin is complexed following
pore formation exist in a bilayer environment as part of per-
meabilized membranes (4, 5). Our data suggest that this is not
a valid assumption to make and that therefore conclusions on
the regions of CBTs that interact with membranes cannot
simply be based on fluorescence data, because lipids complexed
with CBT oligomers apparently exist in a variety of environ-
ments where solid state NMR can be used to distinguish and
quantitate in an approximate way.
It is possible to obtain a lower limit for the life-time of the
existence of proteolipid rings from the 31P MAS NMR spectra.
Two well resolved lines, arising from the two distinct lipid
populations, are observed at a CS separation of ;2 ppm (Fig. 4,
Table I). The FWHH of the resonance from the nonbilayer
environment is ;0.3 ppm. This suggests that any putative
exchange of lipid molecules between the bilayer and the non-
bilayer lipid environments may occur at a rate much slower
than 60 Hz (;1.7 ppm at 500 MHz) or the nonbilayer phase is
stable over times exceeding 15 ms.
The freeze-fracture electron micrographs of pneumolysin-
containing lipid systems (Fig. 5a) are produced by rapid (;104
degrees/second) freezing and reveal the presence of small lipid
vesicles derived from the initial suspension, interacting in a
toxin-independent fashion with the remaining lipid. These
small vesicles appear in the immediate vicinity of the other
lipid structures, trapped between larger lipid aggregates, indi-
cating that such toxin-free structures coexist along with other
vesicles or liposome-containing toxin. Bearing in mind that the
location of these liposomes is within the pneumolysin-induced
aggregate, it is reasonable to deduce that they result from the
effect of pneumolysin on membranes. The data suggest that the
mechanism of pore formation firstly involves oligomerization
on or in a bilayer but that later the oligomeric rings enter free
solution, withdrawing a large fraction of the lipid membrane
into the rings (Fig. 6).
A number of conductance experiments carried out on CBTs
indicate that they create pores of a range of sizes and lifetimes
in membranes, the smallest of which may be blocked using
divalent cations (24). This observation indicates that pores do
indeed form within membranes. What our results indicate is
that the precise nature of such pores is still uncertain, and may
involve lesions formed at the interfaces of nascent oligomeric
structures and lipids (25) and discrete protein complexes
FIG. 5. Two freeze-fracture electron micrographs (a, b) from PC/cholesterol/DCP LUV dispersions in the presence of 1.5 mol %
pneumolysin. The length of the scale bar is 100 nm. Arrow P shows a membrane pore and arrow R shows a proteolipid ring (a). The arrow in b
shows a proteolipid structure at the interface of two fused liposomes.
FIG. 6. Schematic illustration of the effects of pneumolysin on
lipid bilayers. Each oligomer is estimated to be complexed with 840 to
1400 phospholipid molecules. Unilamellar vesicles are ;100 nm in
diameter, and the size of the phospholipid aggregate is much greater
than 100 nm. Exchange of phospholipid between the structures, if
possible, occurs slowly (15 ms).
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within membranes (3) but also large holes in the bilayer alone.
Furthermore, effects downstream of oligomerization and pore-
formation involving large scale redistribution of membrane
components are indicated by our data. It is suggested that the
lytic action of pneumolysin on lipid bilayers is a complex com-
bination of pore formation within the membrane, extraction of
lipid into free oligomeric complexes, aggregation and fusion of
membranes, and membrane destabilization leading to forma-
tion of small vesicles. These observations suggest that CBTs
may not only permeabilize cell membranes but also cause them
to bleb, to aggregate, and to fuse.
The appearance of a large proportion of the lipid and protein
as free oligomer-lipid complexes is also important for under-
standing the noncytolytic mechanisms associated with pneu-
molysin. As mentioned above, pneumolysin has the ability di-
rectly to activate the complement system in a nonimmuno-
specific manner. This occurs by the classical pathway as a result of
the interaction of pneumolysin, IgG-Fc, and complement compo-
nents (8). Toxin oligomers are known to be capable of complement
activation (8), and the existence of large numbers of free oligomers
in solution might explain this facility. Although streptolysin has
been reported to activate complement in the presence of anti-strep-
tolysin antibodies (26), nonimmunospecific activation of comple-
ment has not been demonstrated so far for other CBTs. The oli-
gomers of streptolysin were also found to have a hyperactivating
effect on complement compared with monomeric toxin. Such a
phenomenon may also occur with pneumolysin, because the do-
main through which pneumolysin activates complement (the C-
terminal domain) has a fold very similar to IgG-Fc, with which it
interacts during complement activation (8, 2, 17). IgG itself has a
hyperactivating effect on complement when oligomerized (27),
which suggests the possibility that the lipids associated with free
oligomers may themselves elicit an immune response because non-
bilayer (nonplanar) lipid structures have been shown to be highly
immunogenic (28). The immunogenicity of such structures is
thought to result from their high curvature (28).
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